Invention Grant
- Patent Title: Glucagon receptor antagonist compounds, compositions containing such compounds and methods of use
-
Application No.: US12227030Application Date: 2007-05-11
-
Publication No.: US07935713B2Publication Date: 2011-05-03
- Inventor: Ronald M. Kim , Emma R. Parmee , Qiang Tan , Cangming Yang , Ashley Rouse Lins
- Applicant: Ronald M. Kim , Emma R. Parmee , Qiang Tan , Cangming Yang , Ashley Rouse Lins
- Applicant Address: US NJ Rahway
- Assignee: Merck Sharp & Dohme Corp.
- Current Assignee: Merck Sharp & Dohme Corp.
- Current Assignee Address: US NJ Rahway
- Agent Heidi M. Struse; Richard C. Billups
- International Application: PCT/US2007/011390 WO 20070511
- International Announcement: WO2007/136577 WO 20071129
- Main IPC: A61K31/47
- IPC: A61K31/47 ; A61K31/4184 ; C07D215/00 ; C07D235/04
Abstract:
Glucagon receptor antagonist compounds are disclosed. The compounds are useful for treating type 2 diabetes and related conditions. Pharmaceutical compositions and methods of treatment are also included.
Public/Granted literature
- US20090105310A1 Glucagon Receptor Antagonist Compounds, Compositions Containing Such Compounds and Methods of Use Public/Granted day:2009-04-23
Information query
